Related Experiment Video
Updated: May 4, 2026

Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Post-licensure rapid immunization safety monitoring program (PRISM) data characterization
Meghan A Baker1, Michael Nguyen2, David V Cole3
1Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, United States; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) program effectively captures vaccine exposures and health outcomes using claims data. This demonstrates its capability for robust vaccine safety surveillance.
Area of Science:
- Public Health
- Pharmacovigilance
- Health Informatics
Background:
- The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) program is part of the FDA's Mini-Sentinel project.
- PRISM utilizes electronic health information for active medical product safety monitoring.
- The study aimed to characterize PRISM's claims-based database for vaccine safety surveillance.
Purpose of the Study:
- To assess the surveillance capabilities of the PRISM program's claims-based distributed database.
- To characterize the data available for vaccine safety monitoring within PRISM.
- To evaluate the completeness and utility of PRISM data for vaccine safety.
Main Methods:
- Characterized vaccine exposures within the PRISM database.
- Quantified additional data gained by integrating immunization registries.
- Compared PRISM vaccination coverage estimates with other data sources (NIS, HEDIS).
- Generated rates of potential health outcomes using ICD-9 codes and standardized algorithms.
Main Results:
- Claims data adequately captured most routine infant, child, adolescent, and adult vaccinations.
- Immunization registries added 5-9% data, with higher percentages for specific vaccines (e.g., Hepatitis B).
- PRISM coverage estimates were similar to but lower than NIS and HEDIS.
- Observed rates of potential health outcomes were generally higher than literature rates for clinically confirmed cases.
Conclusions:
- PRISM's data on vaccine exposures are sufficiently complete for effective safety monitoring.
- The program's data on health outcomes support robust safety surveillance.
- PRISM demonstrates strong potential for active vaccine safety monitoring using electronic health data.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Methods of Documentation II: POMR
Principles of Disease Surveillance

